Visual field constriction in children with epilepsy on vigabatrin treatment

Pediatrics

Volumn 106, Issue 4 I, 2000, Pages 838-842

  Iannetti, Paola ^a   Spalice, Alberto ^a   Perla, Francesco Massimo ^a   Conicella, Elena ^a   Raucci, Umberto ^a   Bizzarri, Barbara ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Epilepsy; Vigabatrin; Visual field

Indexed keywords

ANTICONVULSIVE AGENT; VIGABATRIN;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; DRUG EFFECT; DRUG MECHANISM; EPILEPSY; EYE FUNDUS; FEMALE; HUMAN; INFANTILE SPASM; INTRAOCULAR PRESSURE; MALE; PERIMETRY; PRIORITY JOURNAL; RETINA CONE; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT;

EID: 0033772632     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.106.4.838     Document Type: Article

References (18)

1. Vigabatrin
2. Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmologic findings
3. Outer retinal dysfunction in patients treated with vigabatrin
4. Severe persistent visual field constriction associated with vigabatrin
5. Severe persistent visual field constriction associated with vigabatrin. Benefit: Risk ratio must be calculated for individual patients
6. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin
7. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin
8. Severe persistent visual field constriction associated with vigabatrin
9. Visual field constriction in children treated with vigabatrin
10. Visual field constriction is not limited to children treated with vigabatrin
11. Infantile spasms and vigabatrin. Visual field defects may be permanent
12. Vigabatrin-associated retinal cone system dysfunction
13. Vigabatrin-associated retinal cone system dysfunction
14. Vigabatrin-associated retinal cone system dysfunction
15. Electroretinographic changes are not associated with loss of visual function in pediatric epileptic patients following treatment with Vigabatrin
16. Study is needed of visual field defects associated with any long term antiepileptic drug
17. Vigabatrin and visual field defects: Is there a link?
18. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers